We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.57 | -1.14% | 49.46 | 48.68 | 49.90 | 49.47 | 48.27 | 49.04 | 4,596,609 | 23:02:26 |
From May 2019 to May 2024
Sanofi SA (SNY) will nominate eight directors to replace Medivation Inc.'s (MDVN) current board as soon as late next week, CNBC's David Faber reported Friday, citing people familiar with the matter.
Goldman Sachs Group Inc. (GS) and Morgan Stanley (MS) have been hired by Sanofi to assist in the matter, the people told CNBC.
The Paris-based drugmaker last week said it sent a letter to Medivation indicating it would attempt to replace its board if Medivation didn't engage in takeover talks. Medivation previously had rejected a $9.3 billion offer from Sanofi, calling it a "substantially inadequate proposal."
Full story at: http://www.cnbc.com/2016/05/13/sanofi-to-nominate-8-people-to-replace-medivation-board.html
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
May 13, 2016 10:03 ET (14:03 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
